Nebraska continues to close the gap in the Big Ten/Abbott blood drive. At the time of this article Wisconsin still leads ...

The win is Abbott’s third in a row in federal court in Chicago where hundreds of cases over specialized formulas for preterm ...

Abbott Laboratories (ABT) stock has drifted slightly lower this month, with shares showing a 7% drop over the past month.

Abbott Laboratories has won a legal case claiming its Similac infant formula caused the death of a baby from necrotizing ...

The projected fair value for Abbott Laboratories is US$95.46 based on 2 Stage Free Cash Flow to Equity Current share price of ...

According to Benzinga Pro, Abbott Laboratories's peer group average for short interest as a percentage of float is 5.57%, ...

The stock's fall snapped a two-day winning streak.

Walmart will become the first U.S. retailer to sell Abbott Laboratories' over-the-counter continuous glucose monitor Lingo in ...

The fate of hundreds of pending cases against Abbott and Mead Johnson hang in the balance with the latest dismissal.

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Compared to the aggregate P/E ratio of the 48.51 in the Health Care Equipment & Supplies industry, Abbott Laboratories Inc. has a lower P/E ratio of 16.02. Shareholders might be inclined to think that ...